News

Public · Published

Dutch Bros Q3 traffic slows, trims full-year outlook below street view

Dutch Bros reported that company-operated same-shop sales rose 5.4% in its latest quarter, while customer visits rose 1%, down from 7.4% and 6.8%, respectively, a year earlier. Revenue increased 30% to $549.8 million, but the company lowered its full-year sales and adjusted EBITDA outlook, with sales now expected to reach $2.1 billion.

Published:

Updated:

What happened

Dutch Bros reported that company-operated same-shop sales rose 5.4% in its latest quarter, while customer visits rose 1%, down from 7.4% and 6.8%, respectively, a year earlier. Revenue increased 30% to $549.8 million, but the company lowered its full-year sales and adjusted EBITDA outlook, with sales now expected to reach $2.1 billion.

Confirmed

Global impact / market context

Slower customer visits may make growth harder to sustain if higher customer spending does not continue to offset weaker traffic. Lower full-year sales and adjusted EBITDA expectations, meaning a measure of operating earnings, could also signal less room for cost increases and may affect investor expectations for future growth.

Analyst inference

The quarter presented a mixed picture: revenue grew 30% and customer tickets, or average customer spending per transaction, rose 4%, but visits slowed and system-wide comparable sales missed estimates. The revised outlook also fell below the cited sales consensus, while adjusted EBITDA guidance moved lower.

Confirmed

What to watch

  1. Watch whether company-operated customer visits stabilize in coming quarters; continued weakness could limit sales growth if higher customer spending per transaction no longer offsets fewer visits. Analyst inference
  2. Compare future sales and adjusted EBITDA results with the revised full-year outlook of $2.1 billion and approximately $380 million, respectively, to see whether performance tracks guidance. Confirmed
  3. Track operating costs alongside traffic and customer tickets, since the article identifies increased costs and suggests they could affect future performance, without quantifying their impact. Confirmed

Evidence